Energy & Chemicals Consulting

Biotechnology

Biotechnologies are applied to manufacture of bio-based chemicals, materials, and fuels from natural raw feedstock. They are also used in both the pharmaceutical (healthcare) and agro-food sectors.

Biotechnologies within industrial processes mainly involve fermentation or enzymatic conversion of biomass-derived feedstock. In a contained environment, genetically modified (GM) or non-GM microorganisms or cell lines from animal or human origin, are cultivated in closed bioreactors to produce a variety of goods. Likewise enzymes, which are derived from these (micro-) organisms, are applied to catalyze a conversion to generate the desired products.

Industrial applications of biotechnologies are relevant in sectors as diverse as the cleaning, textiles, food, fuels, bulk, and specialty chemicals, monomers and polymers, solvents and adhesives industries. About 5% of chemical sales are dependent on biotech processes.

Nexant's biotechnology consultancy has over 20 years of experience assisting companies working in the biotechnology area in making complex business, technology, and investment decisions under current market conditions. Our international teams use a tailored, multidisciplinary approach that combines extensive industry knowledge with experience.

  • Biochemical screening analyses
  • Project feasibility studies
  • Project development
  • Engineering, procurement, and construction management
  • Analysis of advanced bio-refinery integration

Nexant's expertise and knowledge of domestic and international markets are crucial for introducing biotechnologies competitively into commercial markets.

We provide clients with an in-depth, focused understanding of key global market and technology trends. Our industry specialists have a wealth of experience that extends from commodity chemicals to nutriceuticals. They combine this expertise with financial skills to develop the cost-benefits of each new process or product allowing us to project market size and value throughout the relevant value chain.

Additional Information
Contact Us

Mark Morgan
Principal
Capabilities

Over the last 20 years, our biotechnology consultancy practice has also been engaged in various multi-client engagements as part of the Nexant Process Evaluation and Research Planning Program (PERP), including the following:

Representative Projects and Case Studies